Announcements Trials
Browse Landscape

Status

Completed 18Recruiting 12Active not recruiting 4Unknown 3Withdrawn 2Terminated 2Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 4Genitourinary 3Head & Neck 2Endocrine 2Tumor-Agnostic 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Pancreatic Neoplasms 1

Interventions

Oxaliplatin 84Bevacizumab 67Capecitabine 65Fluorouracil 47Drug Therapy 42tislelizumab 41Gemcitabine 40sintilimab 37Leucovorin 36Irinotecan 33lenvatinib 28Cisplatin 25HMPL-013 24S 1 (combination) 22Immune Checkpoint Inhibitors 22camrelizumab 21irinotecan sucrosofate 20Surgical Procedures, Operative 19Radiotherapy 19Paclitaxel 19130-nm albumin-bound paclitaxel 19apatinib 18toripalimab 17Injections 17Folfox protocol 17pembrolizumab 15Immunotherapy 15Specimen Handling 14Cetuximab 14Radiosurgery 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Interviews as Topic × Gastrointestinal × Clear all
NCT07591480 2026-05-15

Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients

M.D. Anderson Cancer Center

Not yet recruiting
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡